![Thomas Bohner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Risk manager in the Pharma and Biotech Practice at Swiss Re.
Extensive know-how in evaluating risk profiles of new pharmaceutical products.
He is on the Board of Directors of Sloning BioTechnology and an Observer on the Boards of Genizon BioSciences.
Dr Bohner’s thesis was honoured with a medal from the Swiss Federal Institute of Technology, Zurich.
Former positions of Thomas Bohner
| Companies | Position | End |
|---|---|---|
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | President | 01/04/2007 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
- Stock Market
- Insiders
- Thomas Bohner
